Clinical Trials · NCT02303730
Exenatide Compared With Insulin Glargine to Change Liver Fat Content in Type 2 Diabetes
- Phase
- Phase 4
- Recruitment status
- Completed
- Sponsor
- Fudan University
- Enrollment
- 76
- Start date
- Mar 2015
- Locations
- 5 sites, China
- Primary endpoint
- Change in liver fat content（%） measured by MRS